On Thursday, September 5, at 11am Eastern Time, Inscopix will be hosting the webinar “Transforming depression with an innovative neurobehavioral assay to assess novel antidepressants”, presented by Dr. Benjamin Siemsen (Senior Manager, Preclinical Pharmacology, Supernus Pharmaceuticals) and Dr. Jonathan Nassi (Senior Director, Translational Science, Inscopix). Please click here for more information and to register.